Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

Human HLA-C*04:01:01 cDNA

Human HLA-C*04:01:01 cDNA from human EBV-transformed B cell line cDNA

Catalog number RDB02886
Resource name Human HLA-C*04:01:01 cDNA
Alternative name HLA-Cw*04011
Clone info. Human HLA-C*04:01:01 cDNA from human EBV-transformed B cell line cDNA.
Vector backbone pcDNA3.1(+) (Plasmid)
Size of vector backbone 5.4 kb
Selectable markers Amp^r (E. coli), Neo^r (mammalian cell)
Gene/insert name Human HLA-Cw*04011 cDNA
Depositor|Developer Akatsuka, Yoshiki |
Other clones in our bank

External Database
Human HLA-Cw*04011

          Reference sequence
            
           
          Sequence RDB02886z.seq
          Remarks, protocol and/or map (gif) RDB02886.gif

          Distribution information

          Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
          Terms and conditions for distribution In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature(s) designated by the DEPOSITOR is requested (Akatsuka et al., Tissue Antigens 59, 502-511 (2002).).
          Ordering Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. 
          Order form 
          [Credit Card Payment]  [Bank Transfer Payment]
          Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]
          提供案内 (日本国内) [open/close]

          提供条件 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Akatsuka et al., Tissue Antigens 59, 502-511 (2002).)。
          提供依頼 手続きの詳細は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。
          提供依頼書 [Word]
          提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]

          Catalog # Resource name Shipping form Fee (non-profit org.)
          RDB02886 Human HLA-C*04:01:01 cDNA DNA solution

          Please review the QC test results indicated by check icon below as well as clone information before placing your order.

          How to cite this biological resource

          Materials & Methods section:

          The Human HLA-C*04:01:01 cDNA was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB02886).

          Reference section:

          Akatsuka, Y., Goldberg, T.A., Kondo, E., Martin, E.G., Obata, Y., Morishima, Y., Takahashi, T., Hansen, J.A., Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Tissue Antigens, 59, 502-511 (2002). PMID 12445320.

          Further references such as user reports and related articles (go to bottom)


          References and tips

          Featured content

          Featured content HLA Clones (en) (English text)
          Featured content HLA Clones (ja) (Japanese text)

          QC test results

          RIKEN BRC has sequenced portions of this material for quality test.
          Please review the QC test results indicated by check icon as well as clone information before placing your order.

          Test sheet RDB19178_B1Ftp1-1.pdf check

          Nucleotide sequence of a portion of this resource (if available).

          Primer: CMV_Forward (Pr0016)
          Region: CMV pro, insert 5'
          Sequence file: RDB19178_B1Fta.seq check
          >02886_19178_B1Ft_3_CMV-Forward_F02_17_ABI24.ab1
              1 NNNNNNNNNT NNNNNNNNNN GGGCGGTAGG CGTGTACGGT GGGAGGTCTA TATAAGCAGA
             61 GCTCTCTGGC TAACTAGAGA ACCCACTGCT TACTGGCTTA TCGAAATTAA TACGACTCAC
            121 TATAGGGAGA CCCAAGCTGG CTAGCGTTTA AACTTAAGCT TTTCTCCCCA GACGCCGAGA
            181 TGCGGGTCAT GGCGCCCCGA ACCCTCATCC TGCTGCTCTC GGGAGCCCTG GCCCTGACCG
            241 AGACCTGGGC CGGCTCCCAC TCCATGAGGT ATTTCTCCAC ATCCGTGTCC TGGCCCGGCC
            301 GCGGGGAGCC CCGCTTCATC GCAGTGGGCT ACGTGGACGA CACGCAGTTC GTGCGGTTCG
            361 ACAGCGACGC CGCGAGTCCA AGAGGGGAGC CGCGGGAGCC GTGGGTGGAG CAGGAGGGGC
            421 CGGAGTATTG GGACCGGGAG ACACAGAAGT ACAAGCGCCA GGCACAGGCT GACCGAGTGA
            481 ACCTGCGGAA ACTGCGCGGC TACTACAACC AGAGCGAGGA CGGGTCTCAC ACCCTCCAGA
            541 GGATGTTTGG CTGCGACCTG NGGCCGGACG GGCGCCTCCT CCGCGGGTAT AACCAGTTCG
            601 CCTACGACGG CAAGGANTAC ATCGCCCTGA ACGANGNTCT GCGCTCCTGG ACCGCCNCGN
            661 ANACGGCGGC TCANATCACC CNNCGNNAGN GGGGANNNNG CCCGTNNNNN NNNNCNNNNG
          721 NNNNNNCNNN NNNNNNN
          //
          Primer: bGH_rev3 (Pr0885)
          Region: bGH p(A), insert 3'
          Sequence file: RDB19178_B1Ftb.seq check
          >02886_19178_B1Ft_3_bGH_rev3_G02_20_ABI24.ab1
              1 NNNNNNNNNN NGNNNNNGGG CANCAACAGN TGGCTGGCAA CTAGAAGGCA CAGTCGAGGC
             61 TGATCAGCGG GTTTAAACGG GCCCTCTAGA CTCGAGCGGC CGCGTCTCAG GCTTTACAAG
            121 CGATGAGAGA CTCATCAGAG CCCTGGGCAC TGTTGCTGGA CGCAGCCTGA GAGCAGCTCC
            181 CTCCTTTTCC ACCTGAGCTC TTCCTCCTAC ACATCACAAC AGCCACCATA GCTCCTAGGA
            241 CAGCTAGGAC AGCCAGGACA GCCAGGCCAG CAACGATGCC CACGATGGGG ATGGTGGGCT
            301 GGGAAGACGG CTTCCATCTC AGGGTGAGGG GCTCCGGCAG CCCCTCGTGC TGAACATGGC
            361 ACGTGTATCT CTGCTCTTCT CCAGAAGGCA CCACCACAGC TGCCCACTTC TGGAAGGTTC
            421 CATCTCCTGC TGGCCTGGTC TCCACAAGCT CGGTGTCCTG AGTTTGGTCC TCCCCATCCC
            481 ACTGCCAGGT CAGTGTGATC TCCGCAGGGT AGAAGCCCAG GGCCCAGCAC CTCAGGGTGG
            541 CCTCATGGTC AGAGACGGGA TGNTGGGTCA CGTGTGTCTT TGGGTGTTCC GCGCGCTGCA
            601 GCGTCTCCTT CCCGTTCTCC AGGTATCTGC GGANCCACTC NACGCACGTG CCCTCCAGGT
            661 ANGCTCTCCG CTGCTCCGCC TCACGGGCCG CCTCCCACTT GCGCTGGNNG ANNNNNNNCN
          721 NNNNNNNNN
          //
          Primer: SV40pro_F (Pr0110)
          Region: NeoR
          Sequence file: RDB19178_B1Ftc.seq check
          >02886_19178_B1Ft_3_SV40pro_F_H02_23_ABI24.ab1
              1 NNNNNNNNNN NNNNNNNNNN NNGNNGCTTT TTTGGANGCC TAGGCTTTTG CAAAAAGCTC
             61 CCGGGNNCTT GTATATCCAT TTTCGGATCT GATCAAGAGA CAGGATGAGG ATCGTTTCGC
            121 ATGATTGAAC AAGATGGATT GCACGCAGGT TCTCCGGCCG CTTGGGTGGA GAGGCTATTC
            181 GGCTATGACT GGGCACAACA GACAATCGGC TGCTCTGATG CCGCCGTGTT CCGGCTGTCA
            241 GCGCAGGGGC GCCCGGTTCT TTTTGTCAAG ACCGACCTGT CCGGTGCCCT GAATGAACTG
            301 CAGGACGAGG CAGCGCGGCT ATCGTGGCTG GCCACGACGG GCGTTCCTTG CGCAGCTGTG
            361 CTCGACGTTG TCACTGAAGC GGGAAGGGAC TGGCTGCTAT TGGGCGAAGT GCCGGGGCAG
            421 GATCTCCTGT CATCTCACCT TGCTCCTGCC GAGAAAGTAT CCATCATGGC TGATGCAATG
            481 CGGCGGCTGC ATACGCTTGA TCCGGCTACC TGCCCATTCG ACCACCAAGC GAAACATCGC
            541 ATCGAGCGAG CACGTACTCG GATGGAAGCC GGTCTTGTCG ATCAGGANGA TCTGGACGAA
            601 GAGCATCANG GGCTCGCGCC AGCCGAACTG TTCGCCAGGC TCAAGGCGCG CATGCCCGAC
            661 NGCNANGNNC TCGTCNTGAC CCNTGGCGAN GCCNGCTTGN CNAANNNCAN NNNGNAAAAT
          721 GNNNNNNTTT NNNNNNNNNN
          //

          Please visit Sequencing and PCR primers for primer information.


          References

          Original, user report and related articles

          original Akatsuka, Y., Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Tissue Antigens, 59, 502-511 (2002). PMID 12445320.
          user_report Banerjee, P.P., KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-gamma-mediated effects. Mol. Immunol. pii: S0161-5890 (18) 30835-6 (2018). PMID 30482463.
          user_report Ichise, H., NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs. Stem Cell Reports 9 (3): 853-867 (2017). PMID 28867344.

          2023.05.02

          GNP_filter3_RDBDEP_html_230501.pl